
IN8BIO INC. DL-,0001
Share · US45674E1091 · INAB · A2QF49 (XNMS)
2,76 EUR
10.06.2025 08:18
Current Prices from IN8BIO INC. DL-,0001
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
INAB
|
USD
|
10.06.2025 08:18
|
3,15 USD
| 3,02 USD
+4,30 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
5,05 % | -14,37 % | -34,22 % | -59,78 % | -71,14 % | -92,60 % | -98,95 % |
Company Profile for IN8BIO INC. DL-,0001 Share
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Company Data
Name IN8BIO INC. DL-,0001
Company IN8bio, Inc.
Symbol INAB
Website
https://in8bio.com
Primary Exchange
Frankfurt

WKN A2QF49
ISIN US45674E1091
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Tai-Wei Ho
Market Capitalization 13 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 350 5th Avenue, 10118 New York
IPO Date 2021-07-30
Stock Splits
Date | Split |
---|---|
06.06.2025 | 1:30 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 6JH.F |
NASDAQ | INAB |
More Shares
Investors who IN8BIO INC. DL-,0001 hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.